Company Information

Operating, investing and financing cash flows.

Cash Flow

IND-SWIFT LABORATORIES LTD.

NSE Code: INDSWFTLABEQ
BSE Code: 532305
ISIN: INE915B01019
Industry: Pharmaceuticals

Financial Data

Cash Flow

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00

Net Profit/Loss Before Extraordinary Items And Tax	50.22	40.94	190.88	105.85	9.69

Net CashFlow From Operating Activities	-40.19	-39.15	-179.77	182.67	136.26
Net Cash Used In Investing Activities	-100.16	-109.67	-104.32	-13.69	2.76
Net Cash Used From Financing Activities	145.26	74.22	699.86	-168.41	-139.59

Net Inc/Dec In Cash And Cash Equivalents	4.90	-74.60	415.77	0.58	-0.57
Cash And Cash Equivalents Begin of Year	410.09	487.62	9.96	9.38	9.95
Cash And Cash Equivalents End Of Year	414.99	413.01	425.73	9.96	9.38

Five-year consolidated Cash Flow for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00

Net Profit/Loss Before Extraordinary Items And Tax	49.05	34.59	195.17	113.17	12.53

Net CashFlow From Operating Activities	-63.18	-25.47	-163.12	194.62	150.27
Net Cash Used In Investing Activities	-72.68	-109.62	-104.32	-13.37	4.77
Net Cash Used From Financing Activities	141.81	69.20	698.91	-185.66	-140.88
Foreign Exchange Gains / Losses	5.49	0.00	0.00	0.00	-4.29
Adjustments On Amalgamation / Merger / Demerger And Others	0.00	0.00	0.45	1.13	0.00

Net Inc/Dec In Cash And Cash Equivalents	11.44	-65.89	431.93	-3.28	9.88
Cash And Cash Equivalents Begin of Year	410.09	493.93	0.00	21.48	11.60
Cash And Cash Equivalents End Of Year	421.52	428.04	431.93	18.20	21.48

Source: Financial statements as reported by the company.